Doctor Matthew M Y Lee

Doctor Matthew M Y Lee

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

Dr Matthew Lee trained in medicine at the University of Edinburgh (MBChB 2010). He undertook general professional training in medicine in South East Scotland (2010-2012) and the West of Scotland (2012-2014). He is a Cardiology Specialist Registrar in the West of Scotland (from 2014) and Clinical Lecturer at the University of Glasgow. He was awarded the Bellahouston Medal for his PhD at the University of Glasgow (2022), based on the SUGAR-DM-HF trial. He is a CardioVascular Clinical Trialists (CVCT) Future Trialists Fellow (from 2022). His interests include clinical trials, HF, cardiomyopathy, obesity/weight loss, diabetes, pharmacotherapy (SGLT2i, GLP-1RA, myosin inhibitors), meta-analysis, systematic review and multi-modality imaging (CMR, renal MRI, TTE, lung ultrasound). He serves on trial steering committees (SEQUOIA-HCM) and clinical event committees (FINEARTS-HF, REVIVED-BCIS2, CABG-ACS).

Presentations Articles

Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)

Event: ESC Congress 2023

Topic: Biomarkers

Session: Novel biomarkers in heart failure

Access

Caloric restriction and structured exercise programmes in HFpEF: do they improve symptoms and functional status?

Event: ESC Congress 2023

Topic: Chronic Heart Failure

Session: Weight loss as a therapeutic target in HFpEF: dawn of a new era?

Access

Lung ultrasound in acute heart failure: association between quality of life, symptoms and B-lines

Event: ESC Congress 2021 - The Digital Experience

Topic: Imaging

Session: Congress committee e-posters choice in heart failure

Access

Does 'scar' at rest echocardiography predict lack of contractility reserve at dobutamine stress echocardiography?

Event: EuroEcho-Imaging 2018

Topic: Stress Echocardiography

Session: Stress Echocardiography

Access

Doctor Matthew M Y Lee

Biography

Contributor content

Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)

Caloric restriction and structured exercise programmes in HFpEF: do they improve symptoms and functional status?

Lung ultrasound in acute heart failure: association between quality of life, symptoms and B-lines

Does 'scar' at rest echocardiography predict lack of contractility reserve at dobutamine stress echocardiography?

ESC 365 is supported by